Merck’s first-of-its-kind cholesterol pill approved, ushering in new wave of treatment

Lipfendra, to be taken once a day, is designed to help lower cholesterol levels beyond what statins alone can achieve.

FDA approves new kind of cholesterol pill

Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.

5 Repatha Side Effects, Plus How the Cholesterol Med Compares to Statins

You've been managing your cholesterol the best you can, but during your last check-up, you received the same message: Your “bad” LDL cholesterol was still too high. So your doctor recommended Repatha, ...
Reuters

FDA approves Amgen's cholesterol-lowering drug Repatha

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Thursday approved Amgen Inc's Repatha drug for patients with hereditary forms of high cholesterol and those with cardiovascular disease.
Reuters

Amgen's Repatha effective; question is for which patients: FDA

WASHINGTON (Reuters) - Amgen Inc's experimental drug Repatha lowered cholesterol in clinical trials and did not cause a marked disparity in deaths or serious adverse events but showed potential safety ...